SCM
PMVP icon

Stonepine Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Stonepine Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$878K Sell
708,102
-442,657
-38% -$563K 0.35% 42
2025
Q4 		$1.44M Sell
1,150,759
-219,380
-16% -$294K 1.05% 28
2025
Q3 		$1.92M Buy
1,370,139
+524,171
+62% +$725K 1.56% 17
2025
Q2 		$897K Buy
845,968
+215,785
+34% +$212K 0.88% 29
2025
Q1 		$687K Buy
630,183
+94,378
+18% +$128K 0.67% 30
2024
Q4 		$809K Buy
+535,805
New +$849K 0.65% 33

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Stonepine Capital Management's PMVP Position: Q1 2026 in Review

Stonepine Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 38% in Q1 2026, selling an estimated $563K and leaving 708,102 shares worth $878K. The position accounts for 0.35% of the portfolio, ranked #42.

Stonepine Capital Management first reported a position in PMVP in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.92M in Q3 2025. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Stonepine Capital Management held 708,102 shares of PMV Pharmaceuticals worth $878K as of Q1 2026.
  • Stonepine Capital Management sold 442,657 PMV Pharmaceuticals shares in Q1 2026, an estimated $563K.
  • PMV Pharmaceuticals made up 0.35% of Stonepine Capital Management's portfolio in Q1 2026, its #42 holding.
  • Stonepine Capital Management first reported a position in PMV Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Stonepine Capital Management's PMV Pharmaceuticals position peaked at $1.92M in Q3 2025.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.